Chadi Hage Chehade, Post-Doctoral Research Fellow at Huntsman Cancer Institute, shared on X:
“Just out in European Urology.
Check out our editorial highlighting a post hoc analysis of ph3 VISION trial prostate cancer.
In patients receiving Lu-177, extent of PSA response correlated with survival outcomes and PROs.”
Source: Chadi Hage Chehade/X
